secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001104659-24-081155
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma appoints KPMG as new independent auditor, replacing Ernst & Young
------------------------------------------------------------------------------

- On July 16, 2024, Traws Pharma's Audit Committee engaged KPMG as its new independent registered public accounting firm for the year ending December 31, 2024.
- During the fiscal years 2022 and 2023 and interim period through July 16, 2024, the company did not consult KPMG on accounting principles or any disagreements/reportable events.
- Ernst & Young provided a letter to the SEC dated July 19, 2024, agreeing with the company's statements regarding the auditor change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/0001104659-24-081155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/tm2419807d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-081155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer